Live feed08:40:59·6mANALYSTRatingvia QuantisnowChardan Capital Markets initiated coverage on ProMIS Neurosciences with a new price targetByQuantisnow·Wall Street's wire, on your screen.PMN· ProMIS Neurosciences Inc.Health CareOriginal source